Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polycomb group RING finger protein 6 (PCGF6) is a member of the Polycomb group family and functions as a key regulator in the PRC1-like complex, which exerts transcriptional repression mainly via chromatin modification, such as monoubiquitination of histone H2A. Unlike canonical PRC1 proteins, PCGF6 binds to promoters with active chromatin marks and has been characterized as a master regulator in maintaining embryonic stem cell identity, positively regulating the expression of core pluripotency factors such as Oct4, Sox2, Nanog, and Lin28. PCGF6’s activity is modulated by cell cycle-dependent phosphorylation, and it interacts with other PcG proteins. Elevated or reduced expression of PCGF6 influences stem cell pluripotency, differentiation, and has roles in various malignancies such as medulloblastoma. There are no specific drugs approved for targeting PCGF6, but its epigenetic regulatory roles render it an attractive target in cancer and regenerative medicine research. Safety concerns center on the potential for wide-reaching effects on gene expression and cell fate due to its central role in epigenetic control.
Drug development targeting PCGF6 would likely involve disruption of its role in chromatin remodeling, PcG complex function, or epigenetic gene regulation. Mechanisms might include inhibition of protein-protein interactions within PRC1, or modulation of its repressive activity on chromatin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycomb group RING finger protein 6 (PCGF6).